Short interest in Y-mAbs Therapeutics Inc (NASDAQ:YMAB) decreased during the last reporting period, falling from 4.80M to 4.19M. This put 11.29% of the company's publicly available shares short.

Short interest for Y-mAbs Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Y-mAbs Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 351.77K shares traded per day, it would take 11.91 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.